• Home Interface Controller

    Sunstein has prosecuted a portfolio of patents devoted to the emerging industry of interactive television. Our client ICTV has developed technology that enables cable television subscribers to receive video programming that allows them to interact with their television to play games, videos and music on demand; browse news, sports and weather; and view targeted interactive advertising.

  • Molecular Diagnostic System

    We obtained the patent for Source Precision Medicine’s molecular diagnostic system that measures cellular gene expression with significant precision to assess and track an individual’s current health, disease status and response to drug therapy, potentially a foundation for the future practice of medicine.

  • Acoustic Analysis of Bone

    Patents prosecuted by Sunstein protect technologies, including transient signal processing techniques developed by the Metra Biosystems division of Quidel Corp., that are used in compact ultrasonic devices to measure bone density as an aid in detecting osteoporosis.

  • Magnetization Technology

    Sunstein successfully negotiated a multi-million dollar settlement on behalf of Comair Rotron, following a jury verdict that our client’s patent was infringed. The patent was directed to important magnetization technology for brushless DC electric motors.

Deep Patent & Trial Experience

Ariad Pharmaceuticals, Inc. v. Eli Lilly and Co.

We participated in the representation of Ariad, obtaining a $65 million jury verdict for infringement of our client’s patents for regulating NF-kappaB cell-signaling activity, the largest verdict in Massachusetts that year.

Exergen Corporation vs. Kaz, USA, Inc.

Sunstein lawyers won a $14.6M verdict for patent infringement following a two-week jury trial for our client Exergen, the people who pioneered the temporal artery thermometer.

FairWarning IP, LLC v. Iatric, Inc.; FairWarning IP, LLC v. CynergisTek, Inc.

In both the District Court and at the Federal Circuit Court of Appeals, Sunstein successfully defended clients Iatric and CynergisTek against claims of patent infringement relating to software for detecting fraud and misuse of protected health information, obtaining judgments of patent invalidity under Section 101.

In disputes over brand names, we have also delivered major successes to our clients.

Winning at Post Grant Proceedings

Motorola Mobility LLC, Google Inc., and Apple Inc. v. Arendi S.A.R.L.

Motorola, Google and Apple attacked the same patent as Samsung raising several additional grounds. Our arguments carried the day and the inter partes review was not instituted, freeing our client’s patent for unfettered assertion in court.

Click here to learn more about Sunstein litigators.

Spotlight on Patents

A recent patent we obtained for our client Nexsan, of Santa Clara, CA,  U.S. Patent No. 9218406 covers a private cloud storage system in which security is maintained by storing the data on devices (sold under the Transporter brand) of  individual users.  Data is shared on a peer-to-peer basis.  A central  server governs access based on user privileges without storing any of  the shared data. This patent has issued in one of the fields in which recent court rulings have been propelling rapid evolution of the law.

In the News

  • Sunstein attorneys “Walk to the Hill” to support legal aid funding. Click here for more re the event.

    (l to r) Lena Cavallo, Sharona Sternberg, Lisa Tittemore, Kerry Timbers, Erin Connors, Arne Hans

  • Winning Patents! Patents we prosecuted resulted in our client, Conformis, obtaining a $10.5 million Settlement. More…

  • 14 Sunstein attorneys named to the Super Lawyers and Rising Stars 2018 roster. More…

  • Lisa Tittemore, SUNSTEIN Litigation Group Co-Chair, was a member of the committee that drafted extensive revisions to Local Rule 16.6, adopted by the U.S. District Court for D.MA effective June 1, 2018.  It is anticipated that the new rule will make the court a more appealing venue for patent litigation.

  • Bruce Sunstein, Tim MurphyKerry TimbersLisa TittemoreLawrence Green  and Steve Abreu named to Best Lawyers in America©, 2019 list. More. . .

  • SUNSTEIN’s Federal Circuit Win in Exergen: Diagnostic Patents Survive Eligibility Challenge

    This is the first Federal Circuit decision upholding the patentability of a diagnostic patent since the Supreme Court struck down a diagnostic invention on patent eligibility grounds in Mayo v. Prometheus in 2012. More. . .  Law360 Article

  • SUNSTEIN has been named a Tier 1 firm in Boston for Litigation – Intellectual Property by U.S. News – Best Lawyers® “Best Law Firms” in 2019.

  • SUNSTEIN has been named a Recommended Firm by Chambers® in 2018.

     

  • Congratulations to our client Draper Laboratory for multiple awards for patents at the BPLA’s “Invented Here!” program. We are proud that Sunstein attorney George Jakobsche prosecuted the patents for Draper. More. . .

  • Sunstein successfully represented long-time client ’47 before USPTO’s TTAB preventing adversary’s registration of a 47 in a circle.  Read more here.

Our Latest Thinking

  • Katherine W. Soule

    To sue for copyright infringement, you must first register your copyright; merely applying is not enough, says Supreme Court. Fourth Estate v. Wall-Street.com. More...

  • Katherine W. Soule

    Despite a statutory phrase indicating otherwise, the litigation costs that a court may award to a successful copyright plaintiff don’t exceed the usual, says Supreme Court. Rimini Street v. Oracle. More...

  • Christopher Lacenere, Ph.D.

    The Federal Circuit reminds us that even brilliant diagnostic inventions may be patent-ineligible when routine and conventional steps are used to apply a disease-related correlation. Athena Diagnostics v. Mayo Collaborative Services. More...

  • Arne Hans, Ph.D.

    Secret sales of one’s invention trigger the patent law’s one-year on-sale bar, the Supreme Court now clarifies. Helsinn Healthcare v. Teva Pharmaceuticals. More...

  • Thomas C. Carey

    The efficiencies that Europe has introduced to privacy regulation may be unavailable to US companies. More...

Free Subscription

See more in Publications/News